Peritoneal transport of cefonicid

Antimicrob Agents Chemother. 1987 Feb;31(2):292-4. doi: 10.1128/AAC.31.2.292.

Abstract

The pharmacokinetic characteristics of cefonicid, a highly protein-bound expanded-spectrum cephalosporin, were examined in six noninfected, clinically stable patients undergoing continuous ambulatory peritoneal dialysis. After a 1.0-g intravenous dose of cefonicid, the mean concentrations in serum were 105 +/- 25 and 35.6 +/- 14.4 micrograms/ml at 3 and 72 h, respectively. Despite a prolonged half-life in serum of 49.7 +/- 18 h, the penetration into peritoneal fluid was low. The average concentration in dialysate over the 72-h study period was 2.7 micrograms/ml. The serum clearance was 2.6 +/- 1.0 ml/min, and the distribution volume was 0.14 +/- 0.02 liter/kg. Dosage recommendations and clinical considerations for cefonicid use in continuous ambulatory peritoneal dialysis patients are discussed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cefamandole / analogs & derivatives*
  • Cefamandole / metabolism
  • Cefamandole / therapeutic use
  • Cefonicid
  • Humans
  • Kidney Failure, Chronic / metabolism
  • Kinetics
  • Peritoneal Cavity / metabolism*
  • Peritoneal Dialysis, Continuous Ambulatory*
  • Peritonitis / drug therapy*

Substances

  • Cefamandole
  • Cefonicid